Relay Therapeutics Stock (NASDAQ: RLAY) stock price, news, charts, stock research, profile.
You can purchase shares of Relay Therapeutics (NASDAQ:RLAY) through any online brokerage.
Other companies in Relay Therapeutics’s space includes: 89bio (NASDAQ:ETNB), Cogent Biosciences (NASDAQ:COGT), Replimune Group (NASDAQ:REPL), Arcutis Biotherapeutics (NASDAQ:ARQT) and Immatics (NASDAQ:IMTX).
Relay Therapeutics has a consensus price target of $24.10.
The stock price for Relay Therapeutics (NASDAQ: RLAY) is $6.23 last updated November 12, 2024 at 5:11 PM EST.
There are no upcoming dividends for Relay Therapeutics.
Relay Therapeutics’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
There is no upcoming split for Relay Therapeutics.
Relay Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.